Neurocrine’s $2.9B Acquisition of Soleno: A Big Move into Rare Disease Market
In a major development in the global biotech sector, Neurocrine Biosciences has announced the acquisition of Soleno Therapeutics…
In a major development in the global biotech sector, Neurocrine Biosciences has announced the acquisition of Soleno Therapeutics…